149 related articles for article (PubMed ID: 22333459)
1. A point mutation in the DNA-binding domain of HPV-2 E2 protein increases its DNA-binding capacity and reverses its transcriptional regulatory activity on the viral early promoter.
Gao C; Pan MM; Lei YJ; Tian LQ; Jiang HY; Li XL; Shi Q; Tian C; Yuan YK; Fan GX; Dong XP
BMC Mol Biol; 2012 Feb; 13():5. PubMed ID: 22333459
[TBL] [Abstract][Full Text] [Related]
2. [The enhancement of DNA binding ability of a mutated E2 (A338V) protein of HPV-2].
Pan MM; Gao C; Li XL; Gong HS; Shi Q; Yuan YK; Fan GX; Dong XP
Bing Du Xue Bao; 2010 May; 26(3):223-7. PubMed ID: 20572344
[TBL] [Abstract][Full Text] [Related]
3. [Transcriptional repressive activity of mutated E2 protein of human papillomavirus 2 (HPV-2) variant].
Lei YJ; Gao C; Jiang HY; Han J; Chen JM; Shi Q; Zhou W; Yuan YK; Dong XP
Bing Du Xue Bao; 2008 Jul; 24(4):268-71. PubMed ID: 18780628
[TBL] [Abstract][Full Text] [Related]
4. HPV-2 isolates from patients with huge verrucae vulgaris possess stronger promoter activities.
Lei YJ; Wang C; Gao C; Jiang HY; Chen JM; Han J; Yuan YK; Dong XP
Intervirology; 2007; 50(5):353-60. PubMed ID: 17728546
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region.
Hernandez-Ramon EE; Burns JE; Zhang W; Walker HF; Allen S; Antson AA; Maitland NJ
J Virol; 2008 May; 82(10):4853-61. PubMed ID: 18337573
[TBL] [Abstract][Full Text] [Related]
6. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition.
Zhan D; Santin AD; Liu Y; Parham GP; Li C; Meyers C; Hermonat PL
J Biol Chem; 1999 Oct; 274(44):31619-24. PubMed ID: 10531369
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
[TBL] [Abstract][Full Text] [Related]
8. The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.
Lace MJ; Anson JR; Thomas GS; Turek LP; Haugen TH
J Virol; 2008 Nov; 82(21):10841-53. PubMed ID: 18753207
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
Hou SY; Wu SY; Chiang CM
J Biol Chem; 2002 Nov; 277(47):45619-29. PubMed ID: 12239214
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency.
Ustav M; Castaneda FR; Reinson T; Männik A; Ustav M
PLoS One; 2015; 10(8):e0135770. PubMed ID: 26288015
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
12. The Cellular DNA Helicase ChlR1 Regulates Chromatin and Nuclear Matrix Attachment of the Human Papillomavirus 16 E2 Protein and High-Copy-Number Viral Genome Establishment.
Harris L; McFarlane-Majeed L; Campos-León K; Roberts S; Parish JL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795438
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.
Dong XP; Stubenrauch F; Beyer-Finkler E; Pfister H
Int J Cancer; 1994 Sep; 58(6):803-8. PubMed ID: 7927871
[TBL] [Abstract][Full Text] [Related]
15. The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity.
Bedrosian CL; Bastia D
Virology; 1990 Feb; 174(2):557-75. PubMed ID: 2154890
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.
Wu MH; Chan JY; Liu PY; Liu ST; Huang SM
Int J Biochem Cell Biol; 2007; 39(2):413-25. PubMed ID: 17092759
[TBL] [Abstract][Full Text] [Related]
17. A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: a hierarchy of E2-binding sites.
Alexander KA; Phelps WC
Biochemistry; 1996 Jul; 35(30):9864-72. PubMed ID: 8703960
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
19. The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation.
Gao LJ; Gu PQ; Zhao W; Ding WY; Zhao XQ; Guo SY; Zhong TY
J Transl Med; 2013 May; 11():118. PubMed ID: 23651874
[TBL] [Abstract][Full Text] [Related]
20. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
